Ignite Creation Date:
2025-12-26 @ 10:44 PM
Ignite Modification Date:
2026-02-22 @ 6:46 PM
Study NCT ID:
NCT02350712
Status:
COMPLETED
Last Update Posted:
2018-09-11
First Post:
2015-01-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Patritumab With Cetuximab and a Platinum Containing Therapy for Patients With Head and Neck Cancer
Sponsor:
Daiichi Sankyo
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
U31287-A-U106
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None